返回
Skeletal Aging
DOI:10.1016/j.mayocp.2022.03.011.png)
摘要
En 中文
Aging represents the single greatest risk factor for chronic diseases, including osteoporosis, a skeletal fragility syndrome that increases fracture risk. Optimizing bone strength throughout life reduces fracture risk. Factors critical for bone strength include nutrition, physical activity, and vitamin D status, whereas unhealthy lifestyles, illnesses, and certain medications (eg, glucocorticoids) are detrimental. Hormonal status is another important determinant of skeletal health, with sex steroid concentrations, particularly estrogen, having major effects on bone remodeling. Aging exacerbates bone loss in both sexes and results in imbalanced bone resorption relative to formation; it is associated with increased marrow adiposity, osteoblast/osteocyte apoptosis, and accumulation of senescent cells. The mechanisms underlying skeletal aging are as diverse as the factors that determine the strength (and thus fragility) of bone. This review updates our current understanding of the epidemiology, pathophysiology, and treatment of osteoporosis and provides an overview of the underlying hallmark mechanisms that drive skeletal aging. (C) 2022 Mayo Foundation for Medical Education and Research
Keyword:
BONE-MINERAL DENSITY
POSTMENOPAUSAL WOMEN
VITAMIN-D
TRABECULAR BONE
OLDER-ADULTS
MARROW FAT
CELLULAR SENESCENCE
ZOLEDRONIC ACID
ELDERLY-WOMEN
FRACTURE PREVENTION
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
6.7
论文数:
1.0W
被引数:
2.2W
机构
暂无机构信息
引用论文
Yoga-based exercise improves balance and mobility in people aged 60 and over: a systematic review and meta-analysis以瑜伽为基础的运动改善60岁及以上人群的平衡和活动能力: 一项系统综述和荟萃分析
AGE AND AGEING
IF7.1
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysisDenosumab或romosozumab治疗原发性骨质疏松症患者的心血管事件风险: 系统回顾和荟萃分析
BONE
IF3.6

